21 Dec 2011
(MENAFN) International Finance Corporation (IFC) agreed to award Hikma Pharmaceuticals a USD110 million loan, as the company seeks to improve access to generic medicine in the Middle East and North Africa, Arabian Business reported.
The company is based in London and was founded in Amman, Jordan in 1978 and 61 percent of its revenues come from the Middle East and North Africa region.
Hikma said in a statement that IFC’s loan will enable Hikma to continue to provide skilled jobs and high-quality medicines to people in the region.
IFC, the World Bank’s private-sector lender, expects to invest USD6 billion in the region over the next three to four years.
05 Aug 2024
With the support of BBK, BIBF and BJA hold a graduation ceremony for journalists completing the training program
29 Jul 2024
BBK discloses its financial results for the half year ended 30th June 2024
09 Jun 2024
BBK Successfully Closes USD Benchmark Bond Offering at $500 Million, in Collaboration with a Consortium of Regional and International Banks.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more